PRDM16 and acute myeloid leukemia: Similarly, previous studies reported on a prognostic value of PRDM16 expression in AML with intermediate-risk cytogenetics and normal karyotype [15, 16], which suggests that PRDM16 may play different roles depending on the broader molecular context.